Cashu | Summary

DJI

-1.90%

SPX

-2.71%

IXIC

-3.56%

FTSE

-0.86%

N225

-1.01%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

-1.90%

SPX

-2.71%

IXIC

-3.56%

FTSE

-0.86%

N225

-1.01%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

45.65M

Dividend Yield

0.00%

P/E Ratio

-5.72

EPS

-8.60

Revenue

10.74M

Avg. Volume

882.00K

About

What does ATHE do?

It seems there is no content provided to summarize. Please provide the text you would like me to summarize.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

Australia

Website

http://www.alteritytherapeutics.com

Recently from Cashu

Cashu

Alterity Therapeutics Advances ATH-1017 in Promising Alzheimer's Treatment Development

3 days ago

Cashu

Alterity Therapeutics: Key Developments and Future Prospects in Neurodegenerative Disease Research

2 months ago

Cashu

Alterity Therapeutics Advances PBT434 for Neurodegenerative Diseases: Promising Phase 2 Results

3 months ago

Stocks

Health Care

athe

Alterity Therapeutics

ASX - ALL MARKETS: ATHE

-0.22 (-4.89%)

4.28

USD

At close at Oct 10, 20:40 UTC